Patient Services Report – July 2025

Report

As patent cliffs and the rise of advanced therapies like cell and gene technologies reshape the pharmaceutical landscape, manufacturers must evolve their patient support strategies. The future lies in smarter, more targeted, and flexible models. Hybrid approaches—combining digital tools with human touchpoints—enable agile resource allocation and elevate patient engagement.